LNC vs LRMR · P/E 4.9, rev $18.21B vs $204.9M cap
Lincoln National Corporation (LNC) versus Larimar Therapeutics Inc (LRMR) — a side-by-side from cached financials, not a winner call.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Larimar Therapeutics Inc (LRMR) is a biotechnology company listed on US.
Latest reported LNC revenue for 2025-12-31 was $18.21B. Net income was $1.18B. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
LRMR does not have a complete income-statement cache yet.
LNC currently screens at market cap $5.94B and trailing P/E 4.9. LRMR currently screens at market cap $204.9M.
Not investment advice. Open the LNC and LRMR stock pages for the full models.
Not investment advice.